Due Oct3020d left
Request of Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response
Department of Health and Human Services · DC · due 5:00 PM ET
25 docs
What government contracts does The Univeristy of Texas M.d. Anderson Cancer Center hold?
The Univeristy of Texas M.d. Anderson Cancer Center holds 17 government contract awards worth $29M on RFPFinder, most from National Institutes of Health (13 awards), mainly under NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology)) and NAICS 541712. 4 of them end in the next 12 months. The latest award on record is dated Sep 30, 2026.
Recent awards
17 awards, newest first| Awarded | Agency | Description | Amount | Source record |
|---|---|---|---|---|
| Aug 6, 2026 | Food and Drug Administration | BAA FY26C1FP7 MD ANDERSON ONCOLOGY CENTER FOR EXCELLENCE (OCE), EVALUATING BAYESIAN EFFECTIVE SAMPLE SIZE AND DECISION…75F40126C00055 | $752K | Source |
| Apr 30, 2026 | Department of Veterans Affairs | RATIFICATION FOR CALIBRATION SERVICES36C25726P0378 | $3K | Source |
| Sep 16, 2025 | Food and Drug Administration | BAA-MD ANDERSON-STATISTICAL DESIGNS AND CONSIDERATIONS FOR DOSE OPTIMIZATION FY25C1FP675F40125C00075 | $1.2M | Source |
| Sep 30, 2024 | Department of Veterans Affairs | MED PHYSICS PEER REVIEW SERVICES36C24524P0903 | $744K | Source |
| Sep 20, 2024 | National Institutes of Health | TIME-RESTRICTED FEEDING FOR PANCREATIC CANCER PREVENTION75N91024F00002 | $552K | Source |
| Jul 26, 2023 | National Institutes of Health | FURTHER DEVELOPMENT OF IPSC-BASED VACCINE FOR COLON CANCER PREVENTION75N91023F00001 | $1.3M | Source |
| Jun 26, 2023 | National Institutes of Health | TARGETING DKK1 WITH A DNA VACCINE TO PREVENT DEVELOPMENT OF MULTIPLE MYELOMA75N91023F00002 | $1.2M | Source |
| Jun 1, 2022 | National Institutes of Health | PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS-- TARGET…75N91022F00001 | $1.1M | Source |
| Sep 16, 2021 | National Institutes of Health | TARGETING STAT3 TO PREVENT COLORECTAL CANCER SECONDARY TO INFLAMMATORY BOWEL DISEASE75N91021F00002 | $930K | Source |
| Sep 16, 2021 | National Institutes of Health | TASK ORDER TITLE: EVALUATION OF REAL-TIME METABOLIC IMAGING BIOMARKERS FOR DETECTION OF PANCREATIC PREMALIGNANT LESIONS75N91021F00003 | $1.2M | Source |
| Dec 1, 2020 | National Institutes of Health | OPERATION AND MAINTENANCE OF THE CHIMPANZEE CARE CENTER (CCC)75N97021C00001 | $8.7M | Source |
| Sep 15, 2019 | National Institutes of Health | CANCER PREVENTION BY VACCINATION AGAINST INDUCED ANTIGENS75N91019F00132 | $1.2M | Source |
| Sep 10, 2019 | National Institutes of Health | OTHER FUNCTIONS - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH75N91019F00129 | $2.0M | Source |
| Sep 1, 2017 | National Institutes of Health | IGF::OT::IGF A PHASE I DOSE ESCALATION STUDY OF TOPICAL BEXAROTENE IN WOMEN AT HIGH RISK FOR BREAST CANCERHHSN26100012 | $556K | Source |
| Sep 19, 2016 | National Institutes of Health | IGF::OT::IGF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF 4-HYDROXYTAMOXIFEN TOPICAL GEL IN WOMEN WITH MAMMO…HHSN26100011 | $2.2M | Source |
| Aug 1, 2015 | National Institutes of Health | IGF::OT::IGF ALTERNATIVE DOSING OF EXEMESTANE IN POSTMENOPAUSAL WOMEN WITH STAGE 0-II ER-POSITIVE BREAST CANCER: A RAND…HHSN26100008 | $1.6M | Source |
| Aug 10, 2009 | National Institutes of Health | BIOMEDICAL (BASIC)HHSN268200900039C | $4.9M | Source |
Contracts ending in the next 12 months
4 awards by period-of-performance end| Ends | Agency | Description | Amount | Source record |
|---|---|---|---|---|
| Oct 25, 2026 | National Institutes of Health | TARGETING DKK1 WITH A DNA VACCINE TO PREVENT DEVELOPMENT OF MULTIPLE MYELOMA75N91023F00002 | $1.2M | Source |
| Dec 19, 2026 | National Institutes of Health | TIME-RESTRICTED FEEDING FOR PANCREATIC CANCER PREVENTION75N91024F00002 | $552K | Source |
| Dec 25, 2026 | National Institutes of Health | FURTHER DEVELOPMENT OF IPSC-BASED VACCINE FOR COLON CANCER PREVENTION75N91023F00001 | $1.3M | Source |
| May 31, 2027 | National Institutes of Health | PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS-- TARGET…75N91022F00001 | $1.1M | Source |
| Sep 29, 2027 | Department of Veterans Affairs | MED PHYSICS PEER REVIEW SERVICES36C24524P0903 | $744K | Source |
Subcontracts received
2 subawards worth $72K reported by prime contractors| Prime contractor | Subawards | Value |
|---|---|---|
| Baylor College of Medicine | 1 | $37K |
| Amentum Technology, Inc. | 1 | $35K |
Recent subawards
| Date | Prime · agency | Description | Amount | Prime award record |
|---|---|---|---|---|
| Aug 27, 2025 | Amentum Technology, Inc.National Aeronautics and Space Administration | ANALYTICAL PROCESSING OF LUMINEX ASSAY AND DATA ANALYSIS | $35K | Prime award |
| Jun 18, 2025 | Baylor College of MedicineNational Institutes of Health | AGREEMENT: $120,870 AMD 1: -$84,279 THE CONTRACTOR SHALL IDENTIFY ALL PROTON TREATED PEDIATRIC PATIENTS AND ALL PHOTON… | $37K | Prime award |
Open solicitations The Univeristy of Texas M.d. Anderson Cancer Center could bid on
Open notices under PSC AN12, The Univeristy of Texas M.d. Anderson Cancer Center's most frequent product and service code, soonest deadline first.
Questions about The Univeristy of Texas M.d. Anderson Cancer Center
What does The Univeristy of Texas M.d. Anderson Cancer Center sell to the government?
The Univeristy of Texas M.d. Anderson Cancer Center's awards on RFPFinder fall mostly under NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology)), NAICS 541712 and PSC AN12. Its most common product and service code is AN12, on 11 awards.
Which agencies buy from The Univeristy of Texas M.d. Anderson Cancer Center?
National Institutes of Health (13 awards), Food and Drug Administration (2 awards) and Department of Veterans Affairs (2 awards) buy the most from The Univeristy of Texas M.d. Anderson Cancer Center on RFPFinder, out of 3 agencies in total.
How much has The Univeristy of Texas M.d. Anderson Cancer Center been awarded in government contracts?
$29M across 17 awards on RFPFinder, August 2009 to September 2026. That is the sum of the award records RFPFinder holds, not a complete history of The Univeristy of Texas M.d. Anderson Cancer Center's government revenue.
Which prime contractors subcontract to The Univeristy of Texas M.d. Anderson Cancer Center?
Prime contractors reported 2 subawards to The Univeristy of Texas M.d. Anderson Cancer Center worth $72K on USAspending.gov, most from Baylor College of Medicine ($37K) and Amentum Technology, Inc. ($35K). These are the subawards under prime contracts for the agencies and codes RFPFinder tracks.
How do I find The Univeristy of Texas M.d. Anderson Cancer Center's UEI or CAGE code?
The Univeristy of Texas M.d. Anderson Cancer Center's UEI on its federal awards is S3GMKS8ELA16. Award records do not carry CAGE codes; search the UEI in SAM.gov's entity search to see the CAGE code and registration status.
Vendor totals add up the award records RFPFinder holds: federal contract awards from USAspending.gov for the agencies and codes behind open notices, and state and local awards from open-data contract registers and purchase-order files. They are not a vendor's complete government revenue, and a register that lists a contract ceiling or repeats a contract can overstate spend. Names are grouped across spellings ("Corp" and "Corporation"); each award links to its source record. Subcontracts are prime contractors' subaward reports on USAspending.gov for the prime awards behind the same agencies and codes, and GSA Schedule contracts come from GSA eLibrary's MAS contractor list; both are matched to vendors by name.